Home › Stock analysis › GELS
Gelteq (GELS) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
What changed since yesterday
- Closed at $0.45, +3.48% vs the prior close of $0.43.
- Volume 40.14K shares, 0.0x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
GELS jumps 3.5% to $0.45. Closed at $0.45, +3.48% vs the prior close of $0.43. Day range $0.43–$0.49, opened at $0.45.
Last close$0.45+3.48%
Day range0.43–0.49
Open0.45
Volume40.14K
52-week range0.39–2.01
Avg volume (20d)1.78M
GELS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — GELS jumps 3.5% to $0.45
- Closed at $0.45, +3.48% vs the prior close of $0.43. Day range $0.43–$0.49, opened at $0.45.
- Volume was 40.14K shares, 0.0x its 50-day average of 3.62M — lighter than usual.
- Price is -23.7% vs its 50-day average ($0.58) and -34.4% vs its 200-day average ($0.68).
- 52-week range $0.39–$2.01; today's close sits at 4% of that range, 77.8% below the 52-week high.
Oct 15, 2026 — GELS slides 4.2% to $0.43, a 3-month low, 7 down days in a row
- Closed at $0.43, -4.22% vs the prior close of $0.45. Day range $0.43–$0.45, opened at $0.45.
- Volume was 18.70K shares, 0.0x its 50-day average of 3.62M — lighter than usual.
- Price is -26.5% vs its 50-day average ($0.59) and -36.8% vs its 200-day average ($0.68).
- 52-week range $0.39–$2.01; today's close sits at 3% of that range, 78.6% below the 52-week high.
- That makes 7 straight losses.
Oct 14, 2026 — GELS slides 6.3% to $0.45, a 3-month low, 6 down days in a row
- Closed at $0.45, -6.25% vs the prior close of $0.48. Day range $0.45–$0.48, opened at $0.47.
- Volume was 38.20K shares, 0.0x its 50-day average of 3.62M — lighter than usual.
- Price is -23.6% vs its 50-day average ($0.59) and -34.2% vs its 200-day average ($0.68).
- 52-week range $0.39–$2.01; today's close sits at 4% of that range, 77.6% below the 52-week high.
- That makes 6 straight losses.
Oct 13, 2026 — GELS dips 2.0% to $0.48, a 3-month low, 5 down days in a row
- Closed at $0.48, -2.04% vs the prior close of $0.49. Day range $0.48–$0.53, opened at $0.49.
- Volume was 62.90K shares, 0.0x its 50-day average of 3.62M — lighter than usual.
- Price is -18.8% vs its 50-day average ($0.59) and -30.0% vs its 200-day average ($0.69).
- 52-week range $0.39–$2.01; today's close sits at 6% of that range, 76.1% below the 52-week high.
- That makes 5 straight losses.
Oct 12, 2026 — GELS slides 6.0% to $0.49, a 3-month low, 4 down days in a row
- Closed at $0.49, -5.95% vs the prior close of $0.52. Day range $0.47–$0.52, opened at $0.50.
- Volume was 52.80K shares, 0.0x its 50-day average of 3.62M — lighter than usual.
- Price is -17.3% vs its 50-day average ($0.59) and -28.8% vs its 200-day average ($0.69).
- 52-week range $0.39–$2.01; today's close sits at 6% of that range, 75.6% below the 52-week high.
- That makes 4 straight losses.
Oct 9, 2026 — GELS slides 5.1% to $0.52, 3 down days in a row
- Closed at $0.52, -5.10% vs the prior close of $0.55. Day range $0.52–$0.56, opened at $0.56.
- Volume was 52.40K shares, 0.0x its 50-day average of 3.62M — lighter than usual.
- Price is -12.1% vs its 50-day average ($0.59) and -24.5% vs its 200-day average ($0.69).
- 52-week range $0.39–$2.01; today's close sits at 8% of that range, 74.1% below the 52-week high.
- That makes 3 straight losses.
Oct 8, 2026 — GELS dips 2.0% to $0.55
- Closed at $0.55, -1.96% vs the prior close of $0.56. Day range $0.54–$0.55, opened at $0.55.
- Volume was 18.60K shares, 0.0x its 50-day average of 3.63M — lighter than usual.
- Price is -7.5% vs its 50-day average ($0.59) and -20.6% vs its 200-day average ($0.69).
- 52-week range $0.39–$2.01; today's close sits at 10% of that range, 72.7% below the 52-week high.
Oct 7, 2026 — GELS slides 3.4% to $0.56
- Closed at $0.56, -3.45% vs the prior close of $0.58. Day range $0.55–$0.58, opened at $0.57.
- Volume was 89.30K shares, 0.0x its 50-day average of 3.63M — lighter than usual.
- Price is -5.7% vs its 50-day average ($0.59) and -19.2% vs its 200-day average ($0.69).
- 52-week range $0.39–$2.01; today's close sits at 11% of that range, 72.1% below the 52-week high.
Oct 6, 2026 — GELS jumps 6.6% to $0.58
- Closed at $0.58, +6.62% vs the prior close of $0.54. Day range $0.52–$0.58, opened at $0.52.
- Volume was 72.50K shares, 0.0x its 50-day average of 3.63M — lighter than usual.
- Price is -2.4% vs its 50-day average ($0.59) and -16.5% vs its 200-day average ($0.69).
- 52-week range $0.39–$2.01; today's close sits at 12% of that range, 71.1% below the 52-week high.
Oct 5, 2026 — GELS jumps 4.4% to $0.54
- Closed at $0.54, +4.41% vs the prior close of $0.52. Day range $0.52–$0.57, opened at $0.54.
- Volume was 37.30K shares, 0.0x its 50-day average of 3.63M — lighter than usual.
- Price is -8.7% vs its 50-day average ($0.60) and -21.9% vs its 200-day average ($0.70).
- 52-week range $0.39–$2.01; today's close sits at 10% of that range, 72.9% below the 52-week high.
Oct 2, 2026 — GELS slides 4.1% to $0.52, a 1-month low
- Closed at $0.52, -4.05% vs the prior close of $0.54. Day range $0.52–$0.54, opened at $0.53.
- Volume was 70.20K shares, 0.0x its 50-day average of 3.64M — lighter than usual.
- Price is -13.1% vs its 50-day average ($0.60) and -25.4% vs its 200-day average ($0.70).
- 52-week range $0.39–$2.01; today's close sits at 8% of that range, 74.1% below the 52-week high.
GELS latest news & SEC filings
Every SEC filing by or about GELS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Jul 6, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 30, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade GELS
- How much it moves: over the last 20 sessions the average daily move was 3.62% (largest 8.5%). That is a volatile stock.
- Liquidity: about 1.78M shares (≈$792.20K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.45 vs a range of $0.39–$2.01 (4% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Jul 6, 2026; 6-K Jun 30, 2026; 6-K Jun 2, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
GELS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.45 | 0.49 | 0.43 | 0.45 | 40.14K |
| Oct 15, 2026 | 0.45 | 0.45 | 0.43 | 0.43 | 18.70K |
| Oct 14, 2026 | 0.47 | 0.48 | 0.45 | 0.45 | 38.20K |
| Oct 13, 2026 | 0.49 | 0.53 | 0.48 | 0.48 | 62.90K |
| Oct 12, 2026 | 0.50 | 0.52 | 0.47 | 0.49 | 52.80K |
| Oct 9, 2026 | 0.56 | 0.56 | 0.52 | 0.52 | 52.40K |
| Oct 8, 2026 | 0.55 | 0.55 | 0.54 | 0.55 | 18.60K |
| Oct 7, 2026 | 0.57 | 0.58 | 0.55 | 0.56 | 89.30K |
| Oct 6, 2026 | 0.52 | 0.58 | 0.52 | 0.58 | 72.50K |
| Oct 5, 2026 | 0.54 | 0.57 | 0.52 | 0.54 | 37.30K |
| Oct 2, 2026 | 0.53 | 0.54 | 0.52 | 0.52 | 70.20K |
| Oct 1, 2026 | 0.53 | 0.55 | 0.50 | 0.54 | 200.30K |
| Sep 30, 2026 | 0.53 | 0.56 | 0.52 | 0.53 | 38.70K |
| Sep 29, 2026 | 0.54 | 0.55 | 0.52 | 0.53 | 55.60K |
| Sep 28, 2026 | 0.55 | 0.56 | 0.53 | 0.55 | 96.00K |
| Sep 25, 2026 | 0.55 | 0.55 | 0.52 | 0.55 | 79.30K |
| Sep 24, 2026 | 0.52 | 0.58 | 0.52 | 0.55 | 284.80K |
| Sep 23, 2026 | 0.54 | 0.64 | 0.53 | 0.60 | 524.20K |
| Sep 22, 2026 | 0.56 | 0.95 | 0.44 | 0.61 | 33.66M |
| Sep 21, 2026 | 0.56 | 0.60 | 0.56 | 0.57 | 31.60K |
About Gelteq
Gelteq (GELS) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SOUTH MELBOURNE VIC. State of incorporation: Australia. Fiscal year ends June 30. SEC CIK 1920092.
GELS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Simon H Szewach | Director | Mar 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Nathan J Givoni | Chief Executive Officer | Mar 18, 2026 |
| Bradley Glenn Karp | Head of Sales and Marketing | Mar 18, 2026 |
| Paul Michael Wynne | Chief Scientific Officer | Mar 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
GELS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
GELS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on GELS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.